BridgeMD

Sign in

Coronary clinical trials

Explore recruiting coronary clinical trials.

Recruiting coronary studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Coronary trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

"MetCool ACS"- Metformin "Cooling" Effect on metformin-naive Patients Treated with PCI because of Acute Coronary Syndrome

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Glutamate infusion for prevention of Acute Kidney Injury in surgery for ischemic heart disease: (GLUTAMICS III = GLUTAmate for Metabolic Intervention in Coronary Surgery III)

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of safety and efficacy of two ticagrelorbased de-escalation antiplatelet strategies in acute coronary syndrome: the randomized, multicenter, double-blind ELECTRA RCT study.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

RIISC Evaluation of low dose colchicine in prevention of ischemic stroke in patients with stroke due to atherosclerosis. Reducing inflammation in ischemic stroke with colchicine (riisc),

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study to see how RO7763505 works and how safe it is when given to healthy people and people with stable heart disease

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Statins to Prevent Immune checkpoint inhibitor-induced pRogression of AtheroscLerosis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Coronary trials by city

Coronary in Toronto Coronary in Vancouver Coronary in Montreal Coronary in Calgary Coronary in Edmonton Coronary in Ottawa Coronary in Winnipeg Coronary in Quebec City Coronary in Hamilton Coronary in Kitchener Coronary in London Coronary in Halifax Coronary in New York Coronary in Los Angeles Coronary in Chicago Coronary in Houston